Personalis settles patent litigation with Foresight, grants license for MRD tests, receives tiered royalties

Personalis, Inc.

Settled pending infringement claims and IPR proceedings with Foresight Diagnostics.
Foresight gets non-exclusive license under Personalis patents for WGS-based MRD tests using phased variants.
Foresight to pay low-single digit tiered royalty on net sales of licensed products/services.
Upon a change of control involving specified acquirers, a low single-digit million one-time fee and slight royalty rate increase apply.
License is perpetual except for patent challenge termination; each party releases claims and covenants not to sue on CNS patents.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.